Why the study?
Does aliskiren protect against myocardial ischaemia-reperfusion injury in an eNOS-dependent manner in mice?
Population
12-week-old male eNOS knockout (eNOS-/-) and wild-type C57BL/6J mice (WT)
Comparison
Aliskiren 50 mg/kg per day orally for 4 weeks vs Untreated/vehicle mice subjected to the same…
Design
Preclinical
Follow-up
4 weeks of treatment, followed by 24 hours of reperfusion
Authors
Loading...
Aliskiren may confer eNOS-dependent protection in murine I/R injury; leaves open clinical translation.
Does aliskiren protect against myocardial ischaemia-reperfusion injury in an eNOS-dependent manner in mice?
Aliskiren protects against myocardial ischaemia-reperfusion injury through an eNOS-dependent mechanism in a mouse model.
Chen et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: